SRDX · IV Rank History

Surmodics, Inc. Common Stock

IV rank shows where SRDX's implied volatility sits within its own recent range: 0 is the lowest reading in the window, 100 the highest. This page gives the 52-week version, the 90-session version our screeners use, the IV percentile, and the daily history.

SRDX's 30-day at-the-money implied volatility was 100.7% as of Nov 18, 2025. Its 52-week IV rank is 71 and its IV percentile is 88%: IV was lower on 88% of the past year's sessions. Over those 52 weeks it ranged from 8.8% (Nov 17, 2025) to 138.0% (Oct 24, 2025). On the 90-session window our screeners use, the IV rank is 71.

SRDX IV rank history

504 sessions

Filled line: 90-session IV rank (0–100, left axis). Dashed line: 30-day at-the-money implied volatility (right axis).

SRDX IV rank and implied volatility as of 2025-11-18

52-Week IV Rank
71
0 = year low, 100 = year high
IV Percentile
88%
of past-year sessions had lower IV
90-Session IV Rank
71
used by our screeners
30-Day ATM IV
100.7%
1-year average 66.2%
7-Day ATM IV
60.9%
90-session rank 17
52-Week IV High
138.0%
2025-10-24
52-Week IV Low
8.8%
2025-11-17
History Since
2023-05-02
609 sessions

How these are measured. Implied volatility here is SRDX's 30-day at-the-money IV: the implied volatility of the calls and puts struck nearest the share price, blended between the expirations on either side of 30 days so every reading covers the same horizon. It's the IV level options traders usually quote, and it doesn't jump when the nearest expiration rolls from a weekly to a monthly. The 7-day figure is the same measure a week out, so it reacts first to near-term events such as earnings.

52-week IV rank = (today's IV − 52-week low) ÷ (52-week high − 52-week low) × 100. IV percentile is the share of the past year's sessions that closed with lower IV than today. The 90-session IV rank applies the same rank formula to the last 90 sessions, so it reacts faster.

A high reading means SRDX options are expensive relative to their own recent history, which is common ahead of earnings or after a sharp move. It says nothing about which way the stock will go. The Vol Arb Screener ranks every tracked symbol by these measures.

SRDX implied volatility by month

MonthAvg ATM IVHighLowAvg IV Rank (90-session)
Nov 2025 (to date) 83.9% 130.8% 8.8% 51
Oct 2025 112.3% 138.0% 82.4% 91
Sep 2025 93.8% 106.2% 81.1% 90
Aug 2025 73.6% 86.9% 64.7% 64
Jul 2025 74.6% 97.7% 51.8% 66
Jun 2025 63.0% 76.6% 45.1% 48
May 2025 58.8% 86.3% 31.4% 43
Apr 2025 49.9% 96.8% 32.0% 39
Mar 2025 54.9% 77.2% 38.2% 58
Feb 2025 68.8% 78.8% 59.2% 91
Jan 2025 54.0% 69.3% 34.1% 69
Dec 2024 37.1% 59.6% 27.0% 40
Nov 2024 34.8% 60.1% 22.1% 36
Oct 2024 40.5% 72.4% 21.6% 44
Sep 2024 30.1% 47.5% 13.1% 25
Aug 2024 22.8% 36.5% 13.4% 8
Jul 2024 48.8% 67.2% 19.5% 42
Jun 2024 55.5% 69.4% 33.1% 42
May 2024 48.6% 80.0% 35.3% 22
Apr 2024 58.4% 71.5% 51.4% 44
Mar 2024 54.6% 66.4% 40.8% 36
Feb 2024 58.5% 86.6% 44.8% 44
Jan 2024 50.6% 60.4% 44.8% 27
Dec 2023 46.1% 56.2% 36.2% 16
Nov 2023 53.8% 69.2% 39.1% 22
Oct 2023 71.4% 81.5% 61.3% 53
Sep 2023 63.1% 90.3% 50.7% 34
Aug 2023 63.6% 78.5% 52.3% 36
Jul 2023 65.4% 74.8% 59.0% 41
Jun 2023 62.4% 81.9% 50.1% 31
May 2023 66.6% 87.6% 53.9% 71

SRDX IV rank: last 30 sessions

DateIV Rank (90-session)30-Day ATM IV7-Day ATM IV
2025-11-18 71 100.7% 60.9%
2025-11-17 0 8.8% 20.0%
2025-11-14 3 30.3% 43.4%
2025-11-13 0 27.4% —
2025-11-11 0 37.3% 66.9%
2025-11-07 85 124.9% 170.4%
2025-11-06 82 122.1% 161.1%
2025-11-05 87 126.9% 159.3%
2025-11-04 90 129.7% 162.4%
2025-11-03 92 130.8% 158.1%
2025-10-31 97 135.2% 158.7%
2025-10-30 97 135.3% —
2025-10-29 95 133.9% —
2025-10-28 93 132.3% —
2025-10-27 93 132.2% —
2025-10-24 100 138.0% —
2025-10-23 100 116.9% —
2025-10-22 89 109.3% —
2025-10-21 100 116.7% —
2025-10-20 83 101.7% —
2025-10-17 100 111.5% —
2025-10-16 95 107.0% —
2025-10-15 53 82.4% 234.5%
2025-10-14 96 107.5% 248.7%
2025-10-13 83 100.0% 190.4%
2025-10-10 93 105.0% 127.2%
2025-10-09 89 102.5% 162.8%
2025-10-08 83 98.7% 132.1%
2025-10-07 73 92.1% —
2025-10-06 93 105.4% 148.8%

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.